Christina Cho

2.7k total citations
63 papers, 670 citations indexed

About

Christina Cho is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Christina Cho has authored 63 papers receiving a total of 670 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Hematology, 19 papers in Public Health, Environmental and Occupational Health and 17 papers in Epidemiology. Recurrent topics in Christina Cho's work include Hematopoietic Stem Cell Transplantation (25 papers), Acute Myeloid Leukemia Research (18 papers) and Acute Lymphoblastic Leukemia research (16 papers). Christina Cho is often cited by papers focused on Hematopoietic Stem Cell Transplantation (25 papers), Acute Myeloid Leukemia Research (18 papers) and Acute Lymphoblastic Leukemia research (16 papers). Christina Cho collaborates with scholars based in United States, Spain and Italy. Christina Cho's co-authors include Marcia Finlayson, Edward Peterson, Miguel‐Angel Perales, Andrew Roth, Alexandra Berk, Jimmie C. Holland, Christian J. Nelson, Sergio Giralt, Ann A. Jakubowski and Roni Tamari and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neuroscience and Blood.

In The Last Decade

Christina Cho

50 papers receiving 654 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christina Cho United States	14	237	168	166	148	132	63	670
Klaus Gasser Austria	9	49 0.2×	38 0.2×	112 0.7×	84 0.6×	63 0.5×	13	661
Carolyn McDonald United States	11	71 0.3×	34 0.2×	78 0.5×	41 0.3×	54 0.4×	19	530
Abdulkader Daif Saudi Arabia	11	85 0.4×	164 1.0×	33 0.2×	78 0.5×	68 0.5×	23	505
MerriKay Oleen-Burkey United States	16	107 0.5×	689 4.1×	134 0.8×	130 0.9×	69 0.5×	28	931
Sophie Kulaga Canada	8	31 0.1×	441 2.6×	59 0.4×	88 0.6×	54 0.4×	10	704
Andrew Lee United States	17	29 0.1×	183 1.1×	38 0.2×	25 0.2×	106 0.8×	33	564
Philipp Klemm Germany	12	69 0.3×	59 0.4×	17 0.1×	83 0.6×	20 0.2×	61	487
Juliette Meunier France	12	96 0.4×	14 0.1×	81 0.5×	31 0.2×	78 0.6×	33	560
Ricardo Alonso Argentina	15	32 0.1×	361 2.1×	57 0.3×	39 0.3×	119 0.9×	80	680
Raj Sengupta United Kingdom	21	347 1.5×	40 0.2×	14 0.1×	110 0.7×	28 0.2×	106	1.1k

Countries citing papers authored by Christina Cho

Since Specialization

Citations

This map shows the geographic impact of Christina Cho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christina Cho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christina Cho more than expected).

Fields of papers citing papers by Christina Cho

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christina Cho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christina Cho. The network helps show where Christina Cho may publish in the future.

Co-authorship network of co-authors of Christina Cho

This figure shows the co-authorship network connecting the top 25 collaborators of Christina Cho. A scholar is included among the top collaborators of Christina Cho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christina Cho. Christina Cho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Amoozgar, Behzad, David H. Vesole, David S. Siegel, et al.. (2025). Impact of Extramedullary Disease on Survival Outcomes in Multiple Myeloma Patients Treated with Ciltacabtagene Autoleucel and Idecabtagene Vicleucel: A Comparative Analysis. Transplantation and Cellular Therapy. 31(2). S237–S238. 1 indexed citations

Melica, Giovanna, Kenneth Seier, Florent Malard, et al.. (2024). Immune reconstitution, vaccine responses, and rituximab use after ex-vivo CD34-selected myeloablative allogenic hematopoietic cell transplantation. Bone Marrow Transplantation. 59(5). 625–629.

Ploeg, Kattria van der, Rosa Sottile, Brian C. Shaffer, et al.. (2023). Emergence of human CMV-induced NKG2C+ NK cells is associated with CD8+ T-cell recovery after allogeneic HCT. Blood Advances. 7(19). 5784–5798. 5 indexed citations

Mehta, Rohan, et al.. (2023). Epidemiology and Independent Prognostic Factors of Patients with Hepatosplenic T-Cell Lymphoma over the Past 2 Decades. Blood. 142(Supplement 1). 6271–6271.

Gelman, Simon, et al.. (2023). Graft-Versus-Host Disease (GvHD) Prophylaxis after Haploidentical Peripheral Blood Stem Cell Transplantation (haplo-PBSCT) Using Abatacept in Combination with Post-Transplant Cyclophosphamide (PTCy). Blood. 142(Supplement 1). 6996–6996.

Fingrut, Warren, Sean M. Devlin, Andrew Lin, et al.. (2023). Insurance Barriers to High-Cost Anti-Infective Medications Post Allogeneic Hematopoietic Cell Transplant. Transplantation and Cellular Therapy. 29(2). S349–S350. 1 indexed citations

Zavras, Phaedon D., Yiqi Su, Jiaqi Fang, et al.. (2022). Outcomes of Refractory Cytomegalovirus Infection in the First Year after Allogeneic Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 28(7). 403.e1–403.e7. 6 indexed citations

Lee, Jeong‐Ok, Jessica Flynn, Molly Maloy, et al.. (2022). CD34+ -selected hematopoietic stem cell transplant conditioned with a myeloablative regimen in patients with advanced myelofibrosis. Bone Marrow Transplantation. 57(7). 1101–1107. 4 indexed citations

Lu, Zhen, Eun‐Ah Bae, Ioannis I. Verginadis, et al.. (2022). Induction of the activating transcription factor-4 in the intratumoral CD8+ T cells sustains their viability and anti-tumor activities. Cancer Immunology Immunotherapy. 72(4). 815–826. 5 indexed citations

10.

Caldararo, Mario, Elizabeth Schmidt, Ioannis Politikos, et al.. (2022). Atypical Pathogens Presenting With Pulmonary Consolidations Detected by Cell-Free DNA Next-Generation Sequencing in Patients With Hematologic Malignancies. Infectious Diseases in Clinical Practice. 30(2). 4 indexed citations

11.

Dahi, Parastoo B., Andrew Lin, Michael Scordo, et al.. (2022). Evaluation of Melphalan Exposure in Lymphoma Patients Undergoing BEAM and Autologous Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 28(8). 485.e1–485.e6. 1 indexed citations

12.

Bewersdorf, Jan Philipp, Abu‐Sayeef Mirza, Alyssa Grimshaw, et al.. (2021). Hypomethylating Agents and FLT3 Inhibitors As Maintenance Treatment for Acute Myeloid Leukemia and Myelodysplastic Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation–A Systematic Review and Meta-Analysis. Transplantation and Cellular Therapy. 27(12). 997.e1–997.e11. 23 indexed citations

13.

Jacob, R., Jessica Flynn, Sean M. Devlin, et al.. (2021). Universal Engraftment after Allogeneic Hematopoietic Cell Transplantation Using Cryopreserved CD34-Selected Grafts. Transplantation and Cellular Therapy. 27(8). 697.e1–697.e5. 6 indexed citations

14.

Bewersdorf, Jan Philipp, Martin S. Tallman, Christina Cho, Amer M. Zeidan, & Maximilian Stahl. (2020). Safety and Efficacy of Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplant in Acute Myeloid Leukemia and Myelodysplastic Syndrome - a Systematic Review and Meta-Analysis. Blood. 136(Supplement 1). 34–35. 5 indexed citations

15.

Lin, Andrew, Jessica Flynn, Carmen Lau, et al.. (2020). Letermovir for Prevention of Cytomegalovirus Reactivation in Haploidentical and Mismatched Adult Donor Allogeneic Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis. Transplantation and Cellular Therapy. 27(1). 85.e1–85.e6. 32 indexed citations

16.

Scordo, Michael, Valkal Bhatt, Patrick Hilden, et al.. (2019). Standard Antithymocyte Globulin Dosing Results in Poorer Outcomes in Overexposed Patients after Ex Vivo CD34+ Selected Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 25(8). 1526–1535. 17 indexed citations

17.

Rondon-Clavo, Carlos, Michael Scordo, Patrick Hilden, et al.. (2018). Early Fluid Overload Is Associated with an Increased Risk of Nonrelapse Mortality after Ex Vivo CD34-Selected Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 24(12). 2517–2522. 14 indexed citations

18.

Barba, Pere, Rodrigo Martino, Qin Zhou, et al.. (2018). CD34+ Cell Selection versus Reduced-Intensity Conditioning and Unmodified Grafts for Allogeneic Hematopoietic Cell Transplantation in Patients Age >50 Years with Acute Myelogenous Leukemia and Myelodysplastic Syndrome. Biology of Blood and Marrow Transplantation. 24(5). 964–972. 16 indexed citations

19.

Shah, Gunjan L., Michael Scordo, Satyajit Kosuri, et al.. (2017). Impact of Toxicity on Survival for Older Adult Patients after CD34+ Selected Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 24(1). 142–149. 13 indexed citations

20.

Nelson, Christian J., Christina Cho, Alexandra Berk, Jimmie C. Holland, & Andrew Roth. (2009). Are Gold Standard Depression Measures Appropriate for Use in Geriatric Cancer Patients? A Systematic Evaluation of Self-Report Depression Instruments Used With Geriatric, Cancer, and Geriatric Cancer Samples. Journal of Clinical Oncology. 28(2). 348–356. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact